bullish

Cipla Ltd

Cipla Ltd - Complex Respiratory Portfolio Growth to Drive Margins

157 Views19 Mar 2024 12:59
Broker
We reiterate a Buy call with a higher PT due to buoyancy in the US, as price erosion pressures ease, volume growth due to drug shortages and focus on complex products.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 1-minute read)
Related Insights
More »
    Loading
Trending Collections
More »
    Loading
Trending Insights
More »
    Loading
Top Unpaywalled Insights
More »
    Loading
Discussions
(Paid Plans Only)
chart-bar
Logo
Sharekhan
External broker reports(aggregated public sources)
Sharekhan
IndiaEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x